Recent News

Breaking News at ASCO: Single-Dose Radiation for Early Breast Cancer

Good Morning America

On Saturday, June 5, 2010, at the American Society of Clinical Oncology meeting in Chicago, CoActive promoted the landmark clinical results of TARGIT single-dose radiation therapy for breast cancer treatment.  The 10-year study showed that a single-dose of radiation at the time of breast cancer surgery is equivalent up to six and a half weeks of traditional radiation therapy and these results were published in the prestigious peer-reviewed publication, The Lancet.  Despite facing stringent embargoes from ASCO and the The Lancet, CoActive was able to secure more than 100 news stories in just one week for this new therapy during the largest cancer meeting in the country.

Here is sampling of news stories that were placed as a result of CoActive's PR efforts.

 

 

Grand Opening Event for the Orthopaedic Trauma Institute

OTI Opening

On February 19, 2009, CoActive and the UCSF Department of Orthopaedics launched the Orthopaedic Trauma Institute, the only Level I trauma center in the city of San Francisco specializing in musculoskeletal injuries resulting from trauma. More than 400 visitors attended the ceremony, including TV and newspaper reporters, state and local legislators and members of the community.

Here is sampling of news stories that were placed as a result of CoActive's PR efforts.

Press Conference at the American Academy of Ophthalmology

Press Conference at AAO

On, Friday, June 23rd, CoActive hosted a press conference for Carl Zeiss Meditec in San Francisco prior to the opening of the American Academy of Ophthalmology (AAO) annual meeting, the largest national ophthalmic convention in the United States. Take a look at the physician testimonials to learn more about the new ophthalmic data management system that was launched at this press conference, with more than 20 journalists present.

Here is sampling of news stories that were placed as a result of CoActive's PR efforts.